Professor Peter O’Brien and Dr Peter Karadakov, together with academic partner Professor Jacques Maddaluno (Rouen) and industrial partners AstraZeneca and YProtech, have been awarded a new Engineering and Physical Sciences Research Council (EPSRC) research grant. The grant is entitled “C–H Functionalisation of Cyclic Ethers: New Routes to 3-D Fragments, Scaffolds and Pharmaceuticals” and will support a post-doctoral researcher for 3.5 years.